Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol (Q44900131)

7 December 2017

Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol (English)

1 reference

7 December 2017

3

1 reference

7 December 2017

Alessandro Serretti

12

0 references

Hans-Jürgen Möller

series ordinal

9

object named as

Hans-Jürgen Möller

1 reference

7 December 2017

1

Ina Giegling

1 reference

7 December 2017

13

Dan Rujescu

1 reference

7 December 2017

5

Annette M Hartmann

1 reference

7 December 2017

6

Marion Friedl

1 reference

7 December 2017

7

Bettina Konte

1 reference

7 December 2017

10

Diana De Ronchi

1 reference

7 December 2017

11

Hans H Stassen

1 reference

7 December 2017

Beatrice Balzarro

2

1 reference

PubMed ID

22893251

7 December 2017

Martin Schäfer

series ordinal

4

1 reference

PubMed ID

22893251

7 December 2017

Philipp Krämer

series ordinal

8

1 reference

7 December 2017

15 August 2012

1 reference

European Archives of Psychiatry and Clinical Neuroscience

7 December 2017

1 reference

7 December 2017

263

1 reference

7 December 2017

1

1 reference

7 December 2017

65-74

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-012-0348-1

7 December 2017

0 references

cites work

Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Impact of TCF4 on the genetics of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Pharmacogenetics of response to antipsychotics in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

The ANKK1 kinase gene and psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Modulation of mesolimbic dopaminergic activity over the rat estrous cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Is the PANSS used correctly? a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Novel genes identified in a high-density genome wide association study for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Genomewide association for schizophrenia in the CATIE study: results of stage 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Controlling the false discovery rate in behavior genetics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Spurious genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0348-1

Genetics in schizophrenia: where are we and what next?

21 January 2018

1 reference

12 December 2020

A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate

1 reference

12 December 2020

Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.

1 reference

12 December 2020

Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia

1 reference

12 December 2020

DRD2 Ser311/Cys311 polymorphism in schizophrenia

1 reference

12 December 2020

Haploview: Visualization and analysis of SNP genotype data

1 reference

12 December 2020

Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

12 December 2020

10.1007/S00406-012-0348-1

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

22893251